Compound 40 (Figure 10) was found to exhibit down-regulation of AR-regulated transcription and suppressed expression of AR-regulated proteins in androgen-dependent prostate cancer cells, 22Rv1-ARE14 and VCaP. This evidence concerns the gene AR and prostate carcinoma.